Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/27/15 → 01/30/21 |
Funding
- CardioCell Limited Liability Company: $272,677.80
A Phase IIa, Single-Blind, Placebo-Controlled, Crossover, Multi-Center, Randomized Study to Assess The Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-Tolerant Allogeneic Mesenchymal Bone Marrow....
- Skopicki, Hal (PI)
- Lawson, William (CoPI)
- Fiorella, David (CoI)
- Bloom, Michelle (CoPI)
- Gruberg, Luis (CoPI)
- Papadimitriou, Lampros (CoPI)
Project: Research